Extrapolating Guselkumab Efficacy to Juvenile Psoriatic Arthritis from Adult Psoriatic Arthritis and Adult and Pediatric Psoriasis Data
gov with the identifiers: NCT02207231 (VOYAGE 1), NCT02207244 (VOYAGE 2), NCT03162796 (DISCOVER-1), NCT03158285 (DISCOVER-2), and NCT03451851 (PROTOSTAR).
Authors
- Valerie Smith
- Herta Crauwels (ORCID: https://orcid.org/0000-0002-4516-8830)
- Sarah Ringold (ORCID: https://orcid.org/0000-0001-8660-0207)
- Tristan Baguet (ORCID: https://orcid.org/0000-0002-1067-9374)
- Soumya D. Chakravarty (ORCID: https://orcid.org/0000-0001-7957-838X)
- Jocelyn H. Leu (ORCID: https://orcid.org/0000-0002-8627-6512)
- Samantha Howard
- Bart van Hartingsveldt
- Meg Jett
- Elizabeth Adamson (ORCID: https://orcid.org/0009-0004-6564-0778)
Institutions
- Johnson & Johnson (United States) (US)
- Johnson & Johnson (United Kingdom) (GB)
- Johnson & Johnson (Netherlands) (NL)
- Drexel University (US)
Publication Details
- Journal
- Pediatric Drugs
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1007/s40272-025-00725-2
- Citations
- 1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.67